PhoenixBio News

PhoenixBio: Explanatory material about business plans and growth potential.

Jun 25 02:30 ET

PhoenixBio: Regarding matters related to dominant shareholders.

Jun 14 02:30 ET

PhoenixBio: About the conclusion of a business alliance agreement with Ecocell Co., Ltd.

Mar 15 02:00 ET

PhoenixBio: Notice Concerning the Recording of Non-Operating Expenses (Foreign Exchange Losses)

Feb 14 01:30 ET

PhoenixBio: Notice of Japanese Patent Assessment for “Human Fatty Liver Model Cells for Use in Screening Methods”

Feb 9 02:00 ET

PhoenixBio: Announcement of the release of the new product “pxB-cells RF”

Jan 31 01:00 ET

PhoenixBio: Notice Concerning Borrowing of Funds

Dec 15, 2023 02:00 ET

PhoenixBio: Notice Concerning the Recording of Non-Operating Income (Foreign Exchange Gains)

Nov 20, 2023 03:25 ET

PhoenixBio: Conclusion of a business partnership agreement with CMIC Pharmascience Co., Ltd.

Sep 15, 2023 03:00 ET

PhoenixBio: Explanatory materials on business plans and growth potential

Jun 28, 2023 02:30 ET

PhoenixBio: Matters relating to controlling shareholders, etc.

Jun 15, 2023 02:30 ET

PhoenixBio: Independent Officer Notification Form

Jun 12, 2023 04:00 ET

PhoenixBio: Announcement of the release of the new product “Premium Hepatocyte Medium “PXB-Shizuku”

Jun 1, 2023 02:00 ET

PhoenixBio: Articles of association 2023-03-01

Mar 2, 2023 01:36 ET

PhoenixBio: Notice on Japanese Patent examination and approval of "Human non-alcoholic Steatohepatitis Model"

Feb 7, 2023 02:00 ET

PhoenixBio Co Ltd: Notice of the basic agreement for business cooperation with TransCure bioServices SAS

Sep 15, 2022 03:00 ET

PhoenixBio Co Ltd: Notice on the inclusion of non-operating income (exchange difference)

Aug 12, 2022 02:30 ET

PhoenixBio Co Ltd: Explanatory materials on business plans and growth potential

Jun 29, 2022 02:30 ET

PhoenixBio Co Ltd: Articles of association 2022-06-28

Jun 28, 2022 03:23 ET

PhoenixBio Co Ltd: Matters relating to controlling shareholders, etc.

Jun 15, 2022 02:30 ET